Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (41-50 of 350) with videos related to

Pageof 35
Sort By:
The American Journal of Medicine|July 1, 1992
Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemiaR Kurzrock, M Talpaz, J U Gutterman
The New England Journal of Medicine|October 13, 1988
The molecular genetics of Philadelphia chromosome-positive leukemiasR Kurzrock, J U Gutterman, M Talpaz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Malignancy-associated Sweet's syndrome: review of the world literatureP R Cohen, M Talpaz, R Kurzrock
British Journal of Haematology|October 1, 1991
Hairy cell leukaemia: review of treatmentR Kurzrock, M Talpaz, J U Gutterman
The American Journal of Medicine|May 1, 1996
Chronic myelogenous leukemia: a reviewJ E Cortes, M Talpaz, H Kantarjian
Hematology/Oncology Clinics of North America|April 1, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemiaH M Kantarjian, R Kurzrock, M Talpaz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
Chronic myelogenous leukemia--update and future directionsH M Kantarjian, A Deisseroth, M Talpaz
The American Journal of Medicine|September 1, 1991
Treatment of cyclic neutropenia with very low doses of GM-CSFR Kurzrock, M Talpaz, J U Gutterman
Gene|June 14, 1995
Interferon-alpha directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: correlation with IFN-alpha treatment outcome in patients with chronic myelogenous leukemiaN L Nicolson, M Talpaz, G L Nicolson
The American Journal of Medicine|October 1, 1995
Interferon-alpha therapy for chronic myelogenous leukemiaM Wetzler, H Kantarjian, R Kurzrock, et al.
Pageof 35

Showing results (41-50 of 350) with videos related to

Sort By:
Pageof 35
The American Journal of Medicine|July 1, 1992
Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemiaR Kurzrock, M Talpaz, J U Gutterman
The New England Journal of Medicine|October 13, 1988
The molecular genetics of Philadelphia chromosome-positive leukemiasR Kurzrock, J U Gutterman, M Talpaz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Malignancy-associated Sweet's syndrome: review of the world literatureP R Cohen, M Talpaz, R Kurzrock
British Journal of Haematology|October 1, 1991
Hairy cell leukaemia: review of treatmentR Kurzrock, M Talpaz, J U Gutterman
The American Journal of Medicine|May 1, 1996
Chronic myelogenous leukemia: a reviewJ E Cortes, M Talpaz, H Kantarjian
Hematology/Oncology Clinics of North America|April 1, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemiaH M Kantarjian, R Kurzrock, M Talpaz
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 1, 1994
Chronic myelogenous leukemia--update and future directionsH M Kantarjian, A Deisseroth, M Talpaz
The American Journal of Medicine|September 1, 1991
Treatment of cyclic neutropenia with very low doses of GM-CSFR Kurzrock, M Talpaz, J U Gutterman
Gene|June 14, 1995
Interferon-alpha directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: correlation with IFN-alpha treatment outcome in patients with chronic myelogenous leukemiaN L Nicolson, M Talpaz, G L Nicolson
The American Journal of Medicine|October 1, 1995
Interferon-alpha therapy for chronic myelogenous leukemiaM Wetzler, H Kantarjian, R Kurzrock, et al.
Pageof 35